Market Research Logo

Global Melanoma Therapeutics Market 2015-2019

Global Melanoma Therapeutics Market 2015-2019

About Melanoma

According to Melanoma Research Foundation, melanoma is usually, but not always, a cancer of the skin. Melanoma is defined as a cancer that occurs in melanocytes (cells that make the pigment melanin). Chest and back in men and legs in women are the most likely parts to be affected with melanoma. CM, MM, and OM are the three major categories of melanoma. The exact etiology of melanoma is unknown. According to the American Skin Association, the incidence of melanoma is increasing worldwide. The median age of diagnosis is 59 years and the median age of death due to melanoma is 67 years.

TechNavio's analysts forecast the Global Melanoma Therapeutics market to grow at a CAGR of 15.40 percent over the period 2014-2019.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global Melanoma Therapeutics market for the period 2015-2019. To calculate the market size, the report considers the revenue generated from the sales of various drugs used in the treatment of melanoma that are available in the market. The market is divided into four segments: CM, OM, MM, and Others.

TechNavio's report, Global Melanoma Therapeutics Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • APAC
  • EMEA
Key Vendors
  • BMS
  • Merck
  • Roche
Other Prominent Vendors
  • AB Science
  • Amgen
  • Bayer
  • Celgene
  • Daiichi Sankyo
  • Eisai
  • Galectin Therapeutics
  • GSK
  • Novartis
  • Pfizer
  • Vical
  • ZIOPHARM
Market Driver
  • Increase in Prevalence of Melanoma
  • For a full, detailed list, view our report
Market Challenge
  • Availability of Alternative Treatments
  • For a full, detailed list, view our report
Market Trend
  • Emergence of Combination Therapies
  • For a full, detailed list, view our report
Key Questions Answered in this Report
  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

Technavio Announces the Publication of its Research Report – Global Melanoma Therapeutics Market 2015-2019

Technavio recognizes the following companies as the key players in the Global Melanoma Therapeutics Market: Bristol-Myers Squibb Co., F. Hoffmann-La Roche Ltd. and Merck & Co. Inc.

Other Prominent Vendors in the market are: AB Science, Amgen, Bayer, Celgene, Daiichi Sankyo, Eisai, GSK, Novartis, Pfizer, Vical and ZIOPHARM

Commenting on the report, an analyst from Technavio’s team said: “The market is expected to grow steadily during the forecast period because of the increased implementation of combination therapies for late stage treatment of the disease. Combination therapies help in the complete removal of tumors and the destruction of cancerous cells.”

According to the report, the number of people being diagnosed with melanoma has increased worldwide. The high prevalence of melanoma among people has increased the demand for drugs used in the treatment of the disease.

Further, the report states that the availability of alternative treatment options such as chemotherapy, radiation therapy, and surgery limits the consumption of melanoma drugs by the patient population. In radiation therapy, ionizing rays are used to destroy the cancerous cells. Surgery, on the other hand, involves the removal of the tumor and is effective only at the early stages of melanoma.

Companies Mentioned

BMS, Merck, Roche, AB Science, Amgen, Bayer, Celgene, Daiichi Sankyo, Eisai, Galectin Therapeutics, GSK, Novartis, Pfizer, Vical, ZIOPHARM

  • Executive Summary
  • List of Abbreviations
  • Scope of the Report
    • Market Overview
    • Product Offerings
  • Market Research Methodology
    • Market Research Process
    • Research Methodology
      • Table Market Research Methodology
  • Introduction
  • Disease Overview
    • Understanding the Disease
      • Table Change of Appearance in Skin Moles: Suspicion of Melanoma
    • Etiology
    • Key Statistics
      • Table New Diagnosed Cases of Melanoma 2012
    • Stages
      • Table Stages of Melanoma
    • Symptoms
    • Checklist of Melanoma
      • Table Checklist of Melanoma
  • Market Landscape
    • Market Overview
      • Table Snapshot of Global Melanoma Therapeutics Market 2014
    • Market Size and Forecast
      • Table Global Melanoma Therapeutics Market 2014-2019 (US$ million)
    • Melanoma Therapeutics Market in US
      • Market Size and Forecast
        • Table Melanoma Therapeutics Market in US 2014-2019 (US$ million)
    • Melanoma Therapeutics Market in UK
      • Market Size and Forecast
        • Table Melanoma Therapeutics Market in UK 2014-2019 (US$ million)
    • Melanoma Therapeutics Market in Japan
      • Market Size and Forecast
        • Table Melanoma Therapeutics Market in Japan 2014-2019 (US$ million)
    • Five Forces Analysis
  • Melanoma Pipeline Landscape
    • Key Emerging Pipeline Molecules
  • Market Segmentation by Category
    • Table Segmentation of Global Melanoma Therapeutics Market by Category
  • Geographical Segmentation
    • Table Segmentation of Global Melanoma Therapeutics Market by Geography 2014
  • Buying Criteria
  • Market Growth Drivers
    • Table Major Drivers of Global Melanoma Therapeutics Market
  • Drivers and their Impact
  • Market Challenges
    • Table Major Challenges in Global Melanoma Therapeutics Market
  • Impact of Drivers and Challenges
  • Market Trends
    • Table Major Trends in Global Melanoma Therapeutics Market
  • Trends and their Impact
  • Vendor Landscape
    • Competitive Scenario
      • Key News
      • Mergers and Acquisitions
    • Market Share Analysis 2014
      • BMS
        • Table BMS: Global Revenue 2009-2012 (US$ million)
        • Table BMS: Revenue of Yervoy in US 2011-2014 (US$ million)
      • Merck
        • Table Merck: YoY Revenue 2010-2013 (US$ billion)
      • Roche
        • Table Roche: Pharmaceutical Sales by Therapeutic Area 2013
      • Others
        • Table Segmentation of Global Melanoma Therapeutics Market by Vendor 2014
    • Other Prominent Vendors
  • Key Vendor Analysis
    • Bristol-Myers Squibb
      • Key Facts
      • Business Overview
      • Key Product Offerings
        • Table Bristol-Myers Squibb: Key Product Offerings (Based on Therapeutic Areas)
      • Revenue by Geography
        • Table Bristol-Myers Squibb: Revenue by Geographical Segmentation 2013
      • Business Strategy
      • Key Information
      • SWOT Analysis
    • F. Hoffmann-La Roche
      • Key Facts
      • Business Overview
      • Business Segmentation
        • Table Business Segmentation of Roche 2013
      • Business Segmentation by Revenue 2012 and 2013
        • Table Roche: Business Segmentation by Revenue 2012 and 2013
      • Sales by Geography
        • Table Roche: Sales by Geography 2013 (Pharmaceuticals Division)
        • Table Roche: Sales by Geography 2013 (Diagnostics Division)
      • Business Strategy
      • Key Information
      • SWOT Analysis
    • Merck
      • Key Facts
      • Business Overview
      • Business Segmentation by Revenue 2013
        • Table Merck: Business Segmentation by Revenue 2013
      • Business Segmentation by Revenue 2012 and 2013
        • Table Merck: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
      • Sales by Geography
        • Table Merck: Sales by Geography 2013
      • Business Strategy
      • Key Developments
      • SWOT Analysis
  • Other Reports in this Series

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report